Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins (original) (raw)

• Rossant, J. & Howard, L. Signaling pathways in vascular development. Annu. Rev. Cell Dev. Biol. 18, 541–573 (2002).
  Article CAS Google Scholar
• De Togni, P. et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703–707 (1994).
  Article CAS Google Scholar
• Rennert, P.D., Browning, J.L., Mebius, R., Mackay, F. & Hochman, P.S. Surface lymphotoxin a/b complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184, 1999–2006 (1996).
  Article CAS Google Scholar
• Mebius, R.E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3, 292–303 (2003).
  Article CAS Google Scholar
• Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M.H. & Pfeffer, K. The lymphotoxin b receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9, 59–70 (1998).
  Article CAS Google Scholar
• Sabin, F.R. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1, 367–391 (1902).
  Article Google Scholar
• van der Putte, S.C.J. The early development of the lymphatic system in mouse embryos. Acta Morphol. Neerl.-Scand. 13, 245–286 (1975).
  CAS PubMed Google Scholar
• Oliver, G. & Detmar, M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 16, 773–783 (2002).
  Article CAS Google Scholar
• Wigle, J.T. & Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769–778 (1999).
  Article CAS Google Scholar
• Wigle, J.T. et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505–1513 (2002).
  Article CAS Google Scholar
• Petrova, T.V. et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593–4599 (2002).
  Article CAS Google Scholar
• Hong, Y.K. et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225, 351–357 (2002).
  Article CAS Google Scholar
• Dumont, D.J. et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946–949 (1998).
  Article CAS Google Scholar
• Kaipainen, A. et al. Expression of the _fms_-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566–3570 (1995).
  Article CAS Google Scholar
• Makinen, T. et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762–4773 (2001).
  Article CAS Google Scholar
• Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423–1425 (1997).
  Article CAS Google Scholar
• Veikkola, T. et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 6, 1223–1231 (2001).
  Article Google Scholar
• Karkkainen, M.J. et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25, 153–159 (2000).
  Article CAS Google Scholar
• Joukov, V. et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898–3911 (1997).
  Article CAS Google Scholar
• Achen, M.G. et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95, 548–553 (1998).
  Article CAS Google Scholar
• Saaristo, A. et al. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16, 1041–1049 (2002).
  Article CAS Google Scholar
• Stacker, S.A. et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274, 32127–32136 (1999).
  Article CAS Google Scholar
• Kukk, E. et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829–3837 (1996).
  CAS PubMed Google Scholar
• Prevo, R., Banerji, S., Ferguson, D.J.P., Clasper, S. & Jackson, D.G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276, 19420–19430 (2001).
  Article CAS Google Scholar
• Breiteneder-Geleff, S. et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154, 385–394 (1999).
  Article CAS Google Scholar
• Schacht, V. et al. T1a/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546–3556 (2003).
  Article CAS Google Scholar
• Baldwin, M.E. et al. The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man. J. Biol. Chem. 276, 19166–19171 (2001).
  Article CAS Google Scholar
• Shalaby, F. et al. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66 (1995).
  Article CAS Google Scholar
• Avantaggiato, V., Orlandini, M., Acampora, D., Oliviero, S. & Simeone, A. Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family. Mech. Dev. 73, 221–224 (1998).
  Article CAS Google Scholar
• Karkkainen, M.J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98, 12677–12682 (2001).
  Article CAS Google Scholar
• Yuan, L. et al. Abnormal lymphatic vessel development in neuropilin-2 mutant mice. Development 129, 4797–4806 (2002).
  CAS PubMed Google Scholar
• Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735–745 (1998).
  Article CAS Google Scholar
• Gale, N.W. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role Is rescued by angiopoietin-1. Dev. Cell 3, 411–423 (2002).
  Article CAS Google Scholar
• Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439 (1996).
  Article CAS Google Scholar
• Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442 (1996).
  Article CAS Google Scholar
• Bellomo, D. et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ. Res. 86, E29–E35 (2000).
  Article CAS Google Scholar
• Aase, K. et al. Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation 104, 358–364 (2001).
  Article CAS Google Scholar
• Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575–583 (2001).
  Article CAS Google Scholar
• Puri, M.C., Rossant, J., Alitalo, K., Bernstein, A. & Partanen, J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14, 5884–5891 (1995).
  Article CAS Google Scholar
• Kubo, H. et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96, 546–553 (2000).
  CAS PubMed Google Scholar
• Laakkonen, P., Porkka, K., Hoffman, J.A. & Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8, 751–755 (2002).
  Article CAS Google Scholar
• Sainio, K. Experimental methods for studying urogenital development. The Kidney. From normal development to congenital disease (eds. Vize, P.D., Woolf, A.S. & Bard, J.B.L.) 327–342 (Elsevier Science, San Diego, 2003).
  Google Scholar
• Sainio, K. et al. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124, 4077–4087 (1997).
  CAS PubMed Google Scholar
• Larsen, W.J. Human Embryology. 192 (Harcourt, New York, 1993).
  Google Scholar